| Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo DJ Greenblatt, JS Harmatz, LL von Moltke, BL Ehrenberg, L Harrel, ... Clinical Pharmacology & Therapeutics 64 (5), 553-561, 1998 | 171 | 1998 |
| A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening Danjou, Paty, Fruncillo, Worthington, Unruh, Cevallos British Journal of Clinical Pharmacology 48 (3), 367-374, 1999 | 166 | 1999 |
| Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance SM Troy, I Lucki, MA Unruh, WH Cevallos, CA Leister, PT Martin, ... Journal of clinical psychopharmacology 20 (3), 328-337, 2000 | 138 | 2000 |
| Lisdexamfetamine Dimesylate: Linear Dose‐Proportionality, Low Intersubject and Intrasubject Variability, and Safety in an Open‐Label Single‐Dose Pharmacokinetic Study in … J Ermer, R Homolka, P Martin, M Buckwalter, J Purkayastha, B Roesch The Journal of Clinical Pharmacology 50 (9), 1001-1010, 2010 | 73 | 2010 |
| Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease DC Metz, V Pratha, P Martin, J Paul, PN Maton, E Lew, JR Pisegna Official journal of the American College of Gastroenterology| ACG 95 (3 …, 2000 | 63 | 2000 |
| Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table study W Smith, H Wan, D Much, AG Robinson, P Martin Clinical Autonomic Research 26, 269-277, 2016 | 58 | 2016 |
| Comparison of dietary phosphate absorption after single doses of lanthanum carbonate and sevelamer carbonate in healthy volunteers: a balance study P Martin, P Wang, A Robinson, L Poole, J Dragone, M Smyth, R Pratt American journal of kidney diseases 57 (5), 700-706, 2011 | 54 | 2011 |
| The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol D Pierce, S Hossack, L Poole, A Robinson, H Van Heusen, P Martin, ... Nephrology Dialysis Transplantation 26 (5), 1615-1621, 2011 | 52 | 2011 |
| Inhibition of pentagastrin-induced gastric acid secretion by intravenous pantoprazole: a dose-response study JR Pisegna, P Martin, W McKeand, G Ohning, JH Walsh, J Paul Official journal of the American College of Gastroenterology| ACG 94 (10 …, 1999 | 49 | 1999 |
| Effects of omeprazole on the pharmacokinetic profiles of lisdexamfetamine dimesylate and extended-release mixed amphetamine salts in adults MB Haffey, M Buckwalter, P Zhang, R Homolka, P Martin, KC Lasseter, ... Postgraduate medicine 121 (5), 11-19, 2009 | 43 | 2009 |
| Bioavailability of once-daily venlafaxine extended release compared with the immediate-release formulation in healthy adult volunteers SM Troy, C Dilea, PT Martin, AS Rosen, RJ Fruncillo, ST Chiang Current therapeutic research 58 (8), 492-503, 1997 | 43 | 1997 |
| Intranasal versus oral administration of lisdexamfetamine dimesylate: a randomized, open-label, two-period, crossover, single-dose, single-centre pharmacokinetic study in … JC Ermer, K Dennis, MB Haffey, WJ Doll, EP Sandefer, M Buckwalter, ... Clinical Drug Investigation 31, 357-370, 2011 | 41 | 2011 |
| Rapid disappearance of zaleplon from breast milk after oral administration to lactating women M Darwish, PT Martin, WH Cevallos, S Tse, S Wheeler, SM Troy The Journal of Clinical Pharmacology 39 (7), 670-674, 1999 | 37 | 1999 |
| Pharmacokinetics of once-daily venlafaxine extended release in healthy volunteers SM Troy, C Dilea, PT Martin, CA Leister, RJ Fruncillo, ST Chiang Current therapeutic research 58 (8), 504-514, 1997 | 37 | 1997 |
| Differences in gastrointestinal calcium absorption after the ingestion of calcium-free phosphate binders GJ Behets, G Dams, SJ Damment, P Martin, ME De Broe, PC d'Haese American Journal of Physiology-Renal Physiology 306 (1), F61-F67, 2014 | 29 | 2014 |
| A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults … M Palmer, L Jennings, DG Silberg, C Bliss, P Martin BMC Pharmacology and Toxicology 19, 1-13, 2018 | 27 | 2018 |
| Pharmacokinetics of etodolac in patients with stable juvenile rheumatoid arthritis JP Boni, JM Korth-Bradley, P Martin, DK Simcoe, LS Richards, ... Clinical therapeutics 21 (10), 1715-1724, 1999 | 27 | 1999 |
| EFFICACY AND SAFETY OF SERTINDOLE IN DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS OF SCHIZOPHRENIC-PATIENTS PT Martin, JA Grebb, PJ Schmitz, TB Sebree, KB Kashkin Schizophrenia Research 11 (2), 107-107, 1994 | 27 | 1994 |
| Pharmacokinetics of coadministered guanfacine extended release and lisdexamfetamine dimesylate B Roesch, ME Corcoran, J Fetterolf, M Haffey, P Martin, P Preston, ... Drugs in R&D 13, 119-128, 2013 | 24 | 2013 |
| Pharmacokinetics of lisdexamfetamine dimesylate after targeted gastrointestinal release or oral administration in healthy adults JC Ermer, MB Haffey, WJ Doll, P Martin, EP Sandefer, K Dennis, ... Drug metabolism and disposition 40 (2), 290-297, 2012 | 24 | 2012 |
